FI973230L - Uusi farmaseuttinen formulaatio - Google Patents

Uusi farmaseuttinen formulaatio Download PDF

Info

Publication number
FI973230L
FI973230L FI973230A FI973230A FI973230L FI 973230 L FI973230 L FI 973230L FI 973230 A FI973230 A FI 973230A FI 973230 A FI973230 A FI 973230A FI 973230 L FI973230 L FI 973230L
Authority
FI
Finland
Prior art keywords
pharmaceutical formulation
new pharmaceutical
new
formulation
pharmaceutical
Prior art date
Application number
FI973230A
Other languages
English (en)
Swedish (sv)
Other versions
FI973230A0 (fi
FI973230A7 (fi
Inventor
Nils-Erik Anders Carlsson
Johan Georg Harmenberg
Bengt Goeran Hersloef
Ann Harriet Marg Kristofferson
Karl Stefan Lundquist
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI973230L publication Critical patent/FI973230L/fi
Publication of FI973230A0 publication Critical patent/FI973230A0/fi
Publication of FI973230A7 publication Critical patent/FI973230A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI973230A 1995-02-06 1996-02-02 Uusi farmaseuttinen formulaatio FI973230A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500112 1995-02-06
PCT/SE1996/000123 WO1996024359A1 (en) 1995-02-06 1996-02-02 Novel pharmaceutical formulation

Publications (3)

Publication Number Publication Date
FI973230L true FI973230L (fi) 1997-08-05
FI973230A0 FI973230A0 (fi) 1997-08-05
FI973230A7 FI973230A7 (fi) 1997-08-05

Family

ID=20396817

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973230A FI973230A7 (fi) 1995-02-06 1996-02-02 Uusi farmaseuttinen formulaatio

Country Status (18)

Country Link
US (1) US6068860A (fi)
EP (1) EP0809501A1 (fi)
JP (1) JPH11509515A (fi)
KR (1) KR19980701958A (fi)
AR (1) AR002274A1 (fi)
AU (1) AU715212B2 (fi)
CA (1) CA2211409A1 (fi)
DZ (1) DZ1965A1 (fi)
FI (1) FI973230A7 (fi)
HR (1) HRP960033A2 (fi)
IL (1) IL116910A0 (fi)
MA (1) MA23799A1 (fi)
NO (1) NO973611L (fi)
NZ (1) NZ301406A (fi)
TN (1) TNSN96023A1 (fi)
WO (1) WO1996024359A1 (fi)
YU (1) YU7196A (fi)
ZA (1) ZA96526B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
FR2814071A1 (fr) * 2000-09-21 2002-03-22 Oreal Composition a base de glycoglyceride et ses utilisations notamment cosmetiques
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CN104117066B (zh) * 2014-07-16 2016-03-02 陈凌 外敷用抗甲状腺软膏的制备方法
US10759163B2 (en) 2014-10-27 2020-09-01 Hewlett-Packard Development Company, L.P. Printing device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE3778972D1 (de) * 1986-06-12 1992-06-17 Liposome Co Inc Mittel unter verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer arzneistoffe.
WO1989005152A1 (en) * 1987-12-09 1989-06-15 The Regents Of The University Of California Liposome-encapsulated anti-viral composition and method
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation

Also Published As

Publication number Publication date
MA23799A1 (fr) 1996-10-01
YU7196A (sh) 1998-09-18
TNSN96023A1 (fr) 2005-03-15
IL116910A0 (en) 1996-09-12
NZ301406A (en) 1999-01-28
AR002274A1 (es) 1998-03-11
JPH11509515A (ja) 1999-08-24
US6068860A (en) 2000-05-30
FI973230A0 (fi) 1997-08-05
NO973611D0 (no) 1997-08-05
WO1996024359A1 (en) 1996-08-15
HRP960033A2 (en) 1997-10-31
EP0809501A1 (en) 1997-12-03
FI973230A7 (fi) 1997-08-05
DZ1965A1 (fr) 2002-07-17
CA2211409A1 (en) 1996-08-15
AU4682096A (en) 1996-08-27
AU715212B2 (en) 2000-01-20
ZA96526B (en) 1996-08-06
KR19980701958A (ko) 1998-06-25
NO973611L (no) 1997-09-26

Similar Documents

Publication Publication Date Title
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
BR9610396A (pt) Formulação farmacêutica
NO20004345D0 (no) Farmasøytisk sammensetning
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
FI973243L (fi) Uusi farmaseuttinen yhdistelmä
DE69525148D1 (de) Pharmazeutische formulierung
ID24654A (id) Formulasi farmasi omeprazola
BR9611367A (pt) Formulação farmacêutic liofilizada estável
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
FI951316L (fi) Peroraalinen formulaatio
BR9610214A (pt) Compostos farmacéuticos
DE69614407D1 (de) Pharmazeutische zusammensetzungen
FI973229A7 (fi) Uusi farmaseuttinen koostumus
LV11727A (lv) Farmaceitiska kompozicija
ITMI941169A0 (it) Formulazioni farmaceutiche
FI973230A7 (fi) Uusi farmaseuttinen formulaatio
FI973280L (fi) Farmaseuttinen koostumus
FI951155A7 (fi) Farmaseuttinen valmiste
BR9606066A (pt) Composto e formulação farmacêutica
BR9605777A (pt) Composição farmacêutica
NO964309D0 (no) Farmasöytisk sammensetning
SE9404195D0 (sv) New pharmaceutical formulation
SE9600141D0 (sv) Pharmaceutical formulation
SE9502453D0 (sv) Drug formulations